Finerenone, Finerenone Bayer, BAY 94-8862, Finerenone
21467
Phase 3 small_molecule active
Quick answer
Finerenone, Finerenone Bayer, BAY 94-8862, Finerenone for Heart failure due to systemic left ventricular systolic dysfunction is a Phase 3 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- Heart failure due to systemic left ventricular systolic dysfunction
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active